← Back to Search

Procedure

Endoscopic Treatment for Gastrointestinal Perforation

Phase 1
Waitlist Available
Research Sponsored by The Oregon Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to undergo general anesthesia
Gastrointestinal fistula and perforation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing whether new endoscopic tools are safe and effective in the treatment of gastrointestinal leaks or perforations, which are currently treated through either open or laparoscopic surgical procedures.

Who is the study for?
This trial is for individuals who can undergo general anesthesia and give informed consent, with a gastrointestinal fistula or perforation. It's not suitable for those with a BMI of 40 or higher, altered gastric anatomy, severe abdominal inflammation or abscesses, contraindications to upper GI endoscopy or colonoscopy, or esophageal strictures.Check my eligibility
What is being tested?
The study is testing new endoscopic tools as an alternative to open or laparoscopic surgery in treating gastrointestinal leaks and perforations. The goal is to see if these less invasive methods are safe and effective.See study design
What are the potential side effects?
Potential side effects may include discomfort at the procedure site, bleeding, infection risk from the intervention, possible adverse reactions to anesthesia used during the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can safely be put under general anesthesia.
Select...
I have a gastrointestinal fistula or perforation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with adverse events as a measure of safety and tolerability

Find a Location

Who is running the clinical trial?

The Oregon ClinicLead Sponsor
13 Previous Clinical Trials
1,465 Total Patients Enrolled

Media Library

Endoscopic Treatment (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT01303653 — Phase 1
Gastrointestinal Fistula Research Study Groups:
Gastrointestinal Fistula Clinical Trial 2023: Endoscopic Treatment Highlights & Side Effects. Trial Name: NCT01303653 — Phase 1
Endoscopic Treatment (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01303653 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How sound is this therapy for individuals?

"The safety of this medication is only supported by a small amount of evidence, so it was rated 1. This study has been classified as Phase 1 and thus provides limited knowledge about its efficacy."

Answered by AI

Is participation in this experiment limited to individuals younger than 85 years of age?

"Individuals aged between 18 and 85 are eligible to participate in this trial."

Answered by AI

To what extent do potential participants need to meet criteria in order to join this research project?

"To qualify for inclusion in this study, candidates must have intestinal fistula and be between 18 and 85 years of age. The trial aims to enrol 25 patients."

Answered by AI

Is this research project presently open to new participants?

"The details published on clinicaltrials.gov indicate that this research endeavour is not recruiting patients currently, with the most recent amendment to its listing occurring in February 2011. Nevertheless, there are presently 110 other trials welcoming participants while this one is inactive."

Answered by AI
~2 spots leftby Apr 2025